BioCentury
ARTICLE | Clinical News

JZP-258: Ph III started

March 23, 2017 8:51 PM UTC

Jazz began a double-blind, placebo-controlled, international Phase III trial to evaluate JZP-258 in about 130 patients....

BCIQ Company Profiles

Jazz Pharmaceuticals plc

BCIQ Target Profiles

GABA B receptor